TC
AVNS icon

Truvestments Capital’s Avanos Medical AVNS Stock Holding History

Truvestments Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$0 Buy
+5
New +$322 ﹤0.01% 867

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Truvestments Capital's AVNS Position: Q3 2018 in Review

Truvestments Capital opened a new position in Avanos Medical (AVNS) in Q3 2018: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #867 among its holdings.

387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Truvestments Capital held 5 shares of Avanos Medical worth $0 as of Q3 2018.
  • Avanos Medical was a new Truvestments Capital position in Q3 2018.
  • Avanos Medical made up ﹤0.01% of Truvestments Capital's portfolio in Q3 2018, its #867 holding.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Truvestments Capital's 13F filing for Q3 2018, filed 22 Oct 2018.